Skip to main content

Chemotherapy-Induced Nausea and Vomiting and cannabis in South Dakota

The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

Listed qualifying condition
✓ Yes
LEGAL
Up to 3 oz of cannabis …
POSSESSION
$75/yr
STATE FEE
7–30 d
TIMELINE
Listed qualifying condition. The state explicitly lists this condition under its medical cannabis program. A certifying physician can pursue state registration for a patient with this diagnosis under the program rules.

South Dakota statute and program

The South Dakota Medical Cannabis Program is the operating authority for South Dakota patient certification. The authoritative legal text is: South Dakota Codified Laws Chapter 34-20G: Medical Cannabis. The program portal is at South Dakota Medical Cannabis Program.

What the evidence says about cannabis and Chemotherapy-Induced Nausea and Vomiting

Two oral synthetic cannabinoids (dronabinol and nabilone) are FDA-approved for chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetic therapy. The 2017 NASEM consensus report concluded that there is substantial evidence supporting their effectiveness in adults.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Chemotherapy-Induced Nausea and Vomiting page.

How to qualify in South Dakota

The South Dakota Medical Cannabis Program requires the following registration steps for a Chemotherapy-Induced Nausea and Vomiting patient (or any qualifying diagnosis):

  1. Get a written certification from a South Dakota-licensed practitioner. Under SDCL Ch. 34-20G (Measure 26 of 2020), any South Dakota-licensed physician, advanced practice registered nurse, or physician assistant may certify a patient. Qualifying debilitating medical conditions include cancer, glaucoma, HIV/AIDS, MS, epilepsy, severe and debilitating pain, severe nausea, seizures, severe and persistent muscle spasms, IBD, Crohn’s, PTSD, ALS, and any condition the practitioner determines is a "debilitating medical condition" under §34-20G-1(2).
  2. Apply through the South Dakota Department of Health medical cannabis portal. The patient creates an account in the South Dakota Department of Health (DOH) medical cannabis registry portal, uploads the practitioner written certification, a South Dakota driver license or state ID, and a passport-style photograph. Caregivers register separately and undergo a state criminal background check.
  3. Pay the state registration fee. The South Dakota medical cannabis patient registry card fee is $75 per year, reduced to $20 for patients receiving SNAP or Medicaid benefits, and waived for patients with documented terminal illness or for veterans receiving VA disability benefits at 50% or greater. Caregivers pay $20.
  4. Receive the card and purchase from a South Dakota dispensary. South Dakota medical cannabis registry cards are issued within roughly 21 days of complete application. With the card, patients may possess up to 3 ounces of cannabis (plus the equivalent in cannabis products) and may purchase from any of the licensed South Dakota medical cannabis dispensaries. South Dakota honors out-of-state medical cards from qualifying states under SDCL §34-20G-25 (visiting-patient provision), which allows out-of-state patients with a valid medical card to purchase in South Dakota for up to one year.
State registration fee
$75
Physician visit (typical)
$150–$300
Certification to card
7–30 days
Out-of-state patients
Eligible
Minors
Eligible with caregiver

For full South Dakota registration steps, fees, and reciprocity rules, see the South Dakota cannabis-laws page.

ICD-10 code

A certifying physician documenting Chemotherapy-Induced Nausea and Vomiting for the South Dakota medical cannabis program will typically record ICD-10 R11.2 or SNOMED-CT 422587007 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does South Dakota list Chemotherapy-Induced Nausea and Vomiting as a qualifying condition for medical cannabis?

Yes. South Dakota explicitly lists Chemotherapy-Induced Nausea and Vomiting as a qualifying condition under South Dakota Medical Cannabis Program. A patient with a documented Chemotherapy-Induced Nausea and Vomiting diagnosis can pursue state-program certification with a physician registered in the state. The qualifying-condition list is published by the state at https://medcannabis.sd.gov/ and may change as regulators add, remove, or refine entries. Inclusion on the list does not guarantee certification — a physician still has to evaluate the patient and decide that medical cannabis is appropriate for that specific case under South Dakota rules.

How do I get a South Dakota medical marijuana card for Chemotherapy-Induced Nausea and Vomiting?

Step one is finding a physician licensed in South Dakota who is registered with South Dakota Medical Cannabis Program and willing to evaluate Chemotherapy-Induced Nausea and Vomiting cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. South Dakota honors out-of-state medical cards under its reciprocity rules — uncommon, and worth verifying before relying on it. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the South Dakota Medical Cannabis Program site at https://medcannabis.sd.gov/; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Chemotherapy-Induced Nausea and Vomiting?

For Chemotherapy-Induced Nausea and Vomiting, evidence is described as strong (e.g. multiple randomized controlled trials or systematic reviews supporting effect). The mmjnow condition page for Chemotherapy-Induced Nausea and Vomiting lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Chemotherapy-Induced Nausea and Vomiting should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Chemotherapy-Induced Nausea and Vomiting and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Chemotherapy-Induced Nausea and Vomiting; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. South Dakota Codified Laws Chapter 34-20G: Medical Cannabisaccessed May 16, 2026
  2. South Dakota Department of Health: Medical Cannabis Programaccessed May 16, 2026
  3. Wikipedia: Cannabis in South Dakotaaccessed May 16, 2026
  4. NASEM: The Health Effects of Cannabis and Cannabinoids (2017)accessed May 14, 2026

    “Conclusive or substantial evidence that oral cannabinoids are effective antiemetics in the treatment of chemotherapy-induced nausea and vomiting.”

  5. NIH NCCIH: Cannabis (Marijuana) and Cannabinoidsaccessed May 14, 2026